{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-002248","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.208333+00:00","generated_at":"2026-06-07T01:35:09.002615+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Hoth Therapeutics files patent for weight loss therapeutic and side effect mitigation","bullets":["Filed a patent application with USPTO on January 8, 2024 for a therapeutic targeting obesity and side effects of weight loss drugs.","Application aims to mitigate adverse effects associated with GLP-1 agonists, anticonvulsants, opioid antagonists, and NRIs.","No details disclosed on the specific compound, mechanism, or development stage."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-002248","json":"https://secwatch.observer/filing/0001213900-24-002248.json","markdown":"https://secwatch.observer/filing/0001213900-24-002248.md","text":"https://secwatch.observer/filing/0001213900-24-002248.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390024002248/0001213900-24-002248-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390024002248/ea191413-8k_hoththera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:35:09.002615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}